[Relationship between ultrastructure of myeloma cells and clinical features in elderly patients with multiple myeloma]. 1998

H Kurabayashi, and K Kubota, and J Tamura, and H Murakami
Department of Medicine, Kusatsu Branch Hospital, Gunma University Hospital.

The relationship between the ultrastructure of plasma cells and clinical features was analyzed in 54 patients with multiple myeloma: 20 elderly patients (9,8 and 3 cases of IgG, IgA and BJP types, respectively; 5,3 and 12 cases in clinical stage I, II and III, respectively) and 34 young patients (16, 10, 1 and 7 cases of IgG, IgA, IgD and BJP types, respectively; 5, 10 and 19 cases in clinical stage I, II and III, respectively). Five-year survival rates of the elderly and young groups were 41.5 and 60.5%, respectively, though the difference of both survival curves was not significant. Response rates of initial therapy in the elderly and young groups were 55 and 56%, respectively (not significant). The number of patients presenting disarrangement of organelles was significantly larger in the elderly group, but those presenting other abnormal structures were equal between both groups. The ratios of dense body, intramitochondrial granules and multilamellar body in bone marrow plasma cells were significantly higher in nonresponders than in responders of the elderly group. The ratios of disarrangement of organelles, single sac loop-like structure and intramitochondrial granules in bone marrow plasma cells were significantly higher in nonresponders than in responders of the young group. It is suggested that the ultrastructure of plasma cells in multiple myeloma differs between elderly and young patients and is useful in predicting the respective clinical features, although drug responses and survival curves do not show a significant difference.

UI MeSH Term Description Entries
D008297 Male Males
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D015996 Survival Rate The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods. Cumulative Survival Rate,Mean Survival Time,Cumulative Survival Rates,Mean Survival Times,Rate, Cumulative Survival,Rate, Survival,Rates, Cumulative Survival,Rates, Survival,Survival Rate, Cumulative,Survival Rates,Survival Rates, Cumulative,Survival Time, Mean,Survival Times, Mean,Time, Mean Survival,Times, Mean Survival

Related Publications

H Kurabayashi, and K Kubota, and J Tamura, and H Murakami
September 2017, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
H Kurabayashi, and K Kubota, and J Tamura, and H Murakami
June 2019, Journal of clinical laboratory analysis,
H Kurabayashi, and K Kubota, and J Tamura, and H Murakami
January 2001, European journal of haematology,
H Kurabayashi, and K Kubota, and J Tamura, and H Murakami
January 1996, Haematologica,
H Kurabayashi, and K Kubota, and J Tamura, and H Murakami
June 2021, Zhongguo shi yan xue ye xue za zhi,
H Kurabayashi, and K Kubota, and J Tamura, and H Murakami
September 2007, Revista medica de Chile,
H Kurabayashi, and K Kubota, and J Tamura, and H Murakami
December 1986, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
H Kurabayashi, and K Kubota, and J Tamura, and H Murakami
January 2019, BioMed research international,
H Kurabayashi, and K Kubota, and J Tamura, and H Murakami
May 1976, British journal of haematology,
H Kurabayashi, and K Kubota, and J Tamura, and H Murakami
July 2018, Journal of biomedical research,
Copied contents to your clipboard!